Home/ Supplements/ Ginkgo/ Ginkgo-PS

Ginkgo-PS

product on market Tablet or Pill USANA Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Ginkgo biloba is associated with cognitive support and improved blood flow, while soy lecithin provides phospholipids for cellular membrane integrity. Research evidence for these effects is generally moderate. The ingredient profile maintains a high safety rating with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Ginkgo-PS
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Tablet(s)
Serving Size
112
Servings
Other Combinations
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

25 mg
Market median: 120.0mg (440 products) 191 studies (A:1, B:71)
125 mg
Market median: 60.0mg (94 products) 13 studies (A:0, B:7)

Other Ingredients

Dextrose Croscarmellose Sodium Silicon Dioxide Ascorbyl Palmitate Dextrin Sodium Carboxymethylcellulose Sodium Citrate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions: Adults, take four (4) tablets daily, preferably with food.

Warnings & Precautions

Contains: Soy.

Keep out of reach of children.

Consult your physician if you are pregnant, nursing, taking a prescription drug, or have a medical condition.

There is a safety seal under the cap. Do not use if the seal is broken or missing.

Formulation Notes

Contains: Soy.

OK

Additional Information

Potency Guaranteed

Laboratory tested, quality guaranteed. Meets USP specifications for uniformity and disintegration, where applicable.

Store below 25(0) C

126.010101 LB.001265

OK

Metadata

Product Details

DSLD Entry Date2019-11-21
Product TypeOther Combinations
FormTablet or Pill
BrandUSANA
DSLD ID201066
Data Updated2026-04-11
Research

Research Evidence

183
Research Sources
55
Avg Quality
86
Systematic Review
78
Meta Analysis
7
Other
4
Clinical Trial
2
Rct
2
Narrative Review
2
Regulatory Source
1
Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008 PubMed DOI
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020 PubMed DOI
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Ginkgo →
Compare

Similar Products

View all Ginkgo products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.